A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma (2014) Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, et al. Journal article Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up (2014) Ugurel S, Mentzel T, Utikal J, Helmbold P, Mohr P, Pföhler C, Schiller M, et al. Journal article Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins (2014) Sanmamed MF, Carranza-Rua O, Alfaro C, Onate C, Martin-Algarra S, Perez G, Landazuri SF, et al. Journal article Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11 (2014) Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JWF Journal article Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants (2012) Heuckmann JM, Balke-Want H, Malchers F, Peifer M, Sos ML, Koker M, Meder L, et al. Journal article Molecular markers in low-grade gliomas: Predictive or prognostic? (2011) Hartmann C, Hentschel B, Tatagiba M, Schramm J, Schnell O, Seidel C, Stein R, et al. Journal article Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting (2000) Rohrbach F, Gerstmayer B, Biburger M, Wels W Journal article, Original article